MicroPort EverPace

MicroPort EverPace is a global medical device company specializing in cardiac rhythm management (CRM) solutions, operating as a key subsidiary of MicroPort Scientific Corporation. The company designs, manufactures, and markets a wide range of implantable devices, including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) systems. Following the acquisition of LivaNova's CRM business in 2018, the company has integrated advanced European engineering with Chinese manufacturing scale. Their product portfolio features innovative technologies such as Bluetooth-enabled remote monitoring and specialized algorithms for arrhythmia detection. MicroPort EverPace serves patients and healthcare providers across major global markets, including Europe, China, and Japan. The company is dedicated to improving the quality of life for patients suffering from bradycardia, tachycardia, and heart failure.